..
2. The study involving more than 30,000 participants, also revealed that AstraZeneca's Covid-19 vaccine was 100% effective against critical disease and hospitalisation.
— BFM News (@NewsBFM) March 22, 2021
The drugmaker adds that the vaccine was 80% effective at preventing the disease in the elderly.
..
Topline results from an interim analysis of AstraZeneca's phase III U.S. trial for its COVID-19 vaccine showed 79% efficacy against symptomatic illness, the company claimed. By @JohnGeverMPT. #IDtwitter https://t.co/OKKNbDZR7o
— MedPage Today (@medpagetoday) March 22, 2021
https://t.co/4mSr7ZhfYh https://t.co/J6yWBkNvRP pic.twitter.com/5qQYoGdlPJ
— KittyPooh (@KittyPo80176717) March 22, 2021
https://t.co/4mSr7ZhfYh https://t.co/J6yWBkNvRP pic.twitter.com/qbz3JCou4O
— KittyPooh (@KittyPo80176717) March 22, 2021
..
